In addition to biomarker and pathological studies (below), a genetic epidemiological (Mendelian randomization) study of genetic proxies for lower IL-6 activity demonstrated that reduced IL-6 activity was associated with a reduced risk of ischaemic stroke. The gene discussed is IL6; the disease is ischemic stroke.